![Student Volunteers Week 2020](/sites/default/files/styles/square_card_l/public/media/images/media-2182.png.webp?itok=MsjwqMpu)
News
Read the latest news and views from Lymphoma Action.
Use the drop down filter to find the most relevant news for you.
![Student Volunteers Week 2020](/sites/default/files/styles/square_card_l/public/media/images/media-2182.png.webp?itok=MsjwqMpu)
![EMA logo](/sites/default/files/styles/square_card_l/public/media/images/media-2075.jpg.webp?itok=b_fM3Le2)
More treatment options for DLBCL, Burkitt lymphoma and CLL
The European Medicines Agency has extended the licensed indications for two lymphoma treatments: rituximab and venetoclax.
![Text that says Results](/sites/default/files/styles/square_card_l/public/media/images/media-71.jpg.webp?itok=UNXuLIDJ)
People with low-risk, high-grade B-cell lymphoma may need fewer cycles of chemotherapy
The FLYER study found that four cycles of R-CHOP was no less effective than six cycles in people with stage 1 or 2 high-grade B-cell lymphoma and no risk factors.
![Time to Talk Day 2020](/sites/default/files/styles/square_card_l/public/media/images/media-2173.png.webp?itok=eeTTZbod)
Our Helpline Services are here for you #TimeToTalk
On Time to Talk Day, our Information and Support Officers encourage anyone affected by lymphoma to contact our Helpline Services if they need someone to talk to.
![World Cancer Day orange logo](/sites/default/files/styles/square_card_l/public/media/images/media-1388.png.webp?itok=WDeSbELG)
Raise awareness of lymphoma on World Cancer Day 2020
Today marks the 20th anniversary of World Cancer Day – a global movement to raise awareness and understanding of cancer and to ensure that cancer treatment and care is equal for all.
![SONGS OF LOVE & LOSS thame concert](/sites/default/files/styles/square_card_l/public/media/images/media-2157.png.webp?itok=1X3HoVmw)
Bucks singer organises concert to support our work
Sara Kalic presents an evening of classical song in Thame on Saturday 8 February.
![Text that says Results](/sites/default/files/styles/square_card_l/public/media/images/media-71.jpg.webp?itok=UNXuLIDJ)
Acalabrutinib shows promise in Waldenström’s macroglobulinaemia
Phase 2 trial finds that acalabrutinib is active and well tolerated in people with Waldenström’s macroglobulinaemia
![Text that says Results](/sites/default/files/styles/square_card_l/public/media/images/media-71.jpg.webp?itok=UNXuLIDJ)
Polatuzumab vedotin improves outcomes for people with relapsed or refractory DLBCL
Promising results published in the Journal of Clinical Oncology in November.
![2020 Lymphoma Coalition Global Patient Survey](/sites/default/files/styles/square_card_l/public/media/images/media-2109.png.webp?itok=-5Rb-hfq)
Take part in the Lymphoma Coalition 2020 Global Patient Survey
We want to hear from you! Please share your experiences in this new survey.
![SMC logo](/sites/default/files/styles/square_card_l/public/media/images/media-2105.png.webp?itok=2k-OdZ35)
New treatment for T-cell skin lymphoma approved in Scotland
Brentuximab vedotin (Adcetris®) is now available on the NHS in Scotland for adults with some advanced T-cell skin lymphomas.